Robert Rothman
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Glaucoma and retinal disorders 4
- Intraocular Surgery and Lenses 2
- Retinal Diseases and Treatments 1
- Retinal and Optic Conditions 1
-
- Chemotherapy-induced organ toxicity mitigation 3
- Co-authors
- Stephen C. Rubin (3 shared papers)Thomas B. Hakes (3 shared papers)Lois Almadrones (3 shared papers)John L. Lewis (2 shared papers)Bonnie Reichman (2 shared papers)Wanda K. Jones (1 shared paper)William J. Hoskins (1 shared paper)Maurie Markman (1 shared paper)
- Journals
- American Journal of Ophthalmology (3 papers)Journal of Glaucoma (3 papers)Journal of Clinical Oncology (1 paper)Ophthalmology (1 paper)Ophthalmic Epidemiology (1 paper)
- Partner nations
- United States
In The Last Decade
Robert Rothman
12 papers receiving 787 citations
Robert Rothman's Hit Papers
Peers
Comparison fields: 5 of 64
- Reproductive Medicine 439
- Obstetrics and Gynecology 102
- Ophthalmology 108
- Oncology 159
- Pathology and Forensic Medicine 80
Countries citing papers authored by Robert Rothman
This map shows the geographic impact of Robert Rothman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Rothman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Rothman more than expected).
Fields of papers citing papers by Robert Rothman
This network shows the impact of papers produced by Robert Rothman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Rothman. The network helps show where Robert Rothman may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Rothman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. Hit paper breakdown → | 1991 | 651 |
| 2 | 2000 | 54 | |
| 3 | 2008 | 34 | |
| 4 | 1991 | 22 | |
| 5 | 2001 | 13 | |
| 6 | 2001 | 10 | |
| 7 | 2001 | 9 | |
| 8 | 2000 | 7 | |
| 9 | 2002 | 6 | |
| 10 | 2005 | 2 | |
| 11 | 1999 | 2 | |
| 12 | 1999 | 2 | |
| 13 | 1991 | 1 | |
| 14 | 2024 | 0 |
About Robert Rothman
Robert Rothman is a scholar working on Ophthalmology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Molecular Biology, having authored 14 papers that have together received 813 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (4 papers), Chemotherapy-induced organ toxicity mitigation (3 papers), Intraocular Surgery and Lenses (2 papers), Retinal Diseases and Treatments (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Retinal and Optic Conditions (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and Magnesium in Health and Disease (1 paper). The work is most often cited by research in Reproductive Medicine (439 citations), Obstetrics and Gynecology (102 citations), Ophthalmology (108 citations), Oncology (159 citations) and Pathology and Forensic Medicine (80 citations). Robert Rothman has collaborated with scholars based in United States. Frequent co-authors include Stephen C. Rubin, Thomas B. Hakes, Lois Almadrones, John L. Lewis, Bonnie Reichman, Wanda K. Jones, William J. Hoskins, Maurie Markman, Jeffrey Liebmann and Robert Ritch. Their work appears in journals such as American Journal of Ophthalmology, Journal of Glaucoma, Journal of Clinical Oncology, Ophthalmology and Ophthalmic Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.